Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Case Report: Repeated Stereotactic Radiotherapy of Recurrent Ventricular Tachycardia: Reasons, Feasibility, and Safety

J. Haskova, P. Peichl, M. Šramko, J. Cvek, L. Knybel, O. Jiravský, R. Neuwirth, J. Kautzner

. 2022 ; 9 (-) : 845382. [pub] 20220328

Jazyk angličtina Země Švýcarsko

Typ dokumentu kazuistiky

Perzistentní odkaz   https://www.medvik.cz/link/bmc22017512

Stereotactic body radiotherapy (SBRT) has been reported as an attractive option for cases of failed catheter ablation of ventricular tachycardia (VT) in structural heart disease. However, even this strategy can fail for various reasons. For the first time, this case series describes three re-do cases of SBRT which were indicated for three different reasons. The purpose in the first case was the inaccuracy of the determination of the treatment volume by indirect comparison of the electroanatomical map and CT scan. A newly developed strategy of co-registration of both images allowed precise targeting of the substrate. In this case, the second treatment volume overlapped by 60% with the first one. The second reason for the re-do of SBRT was an unusual character of the substrate-large cardiac fibroma associated with different morphologies of VT from two locations around the tumor. The planned treatment volumes did not overlap. The third reason for repeated SBRT was the large intramural substrate in the setting of advanced heart failure. The first treatment volume targeted arrhythmias originating in the basal inferoseptal region, while the second SBRT was focused on adjacent basal septum without significant overlapping. Our observations suggested that SBRT for VT could be safely repeated in case of later arrhythmia recurrences (i.e., after at least 6 weeks). No acute toxicity was observed and in two cases, no side effects were observed during 32 and 22 months, respectively. To avoid re-do SBRT due to inaccurate targeting, the precise and reproducible strategy of substrate identification and co-registration with CT image should be used.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22017512
003      
CZ-PrNML
005      
20220720100246.0
007      
ta
008      
220718s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fcvm.2022.845382 $2 doi
035    __
$a (PubMed)35425817
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Haskova, Jana $u Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia
245    10
$a Case Report: Repeated Stereotactic Radiotherapy of Recurrent Ventricular Tachycardia: Reasons, Feasibility, and Safety / $c J. Haskova, P. Peichl, M. Šramko, J. Cvek, L. Knybel, O. Jiravský, R. Neuwirth, J. Kautzner
520    9_
$a Stereotactic body radiotherapy (SBRT) has been reported as an attractive option for cases of failed catheter ablation of ventricular tachycardia (VT) in structural heart disease. However, even this strategy can fail for various reasons. For the first time, this case series describes three re-do cases of SBRT which were indicated for three different reasons. The purpose in the first case was the inaccuracy of the determination of the treatment volume by indirect comparison of the electroanatomical map and CT scan. A newly developed strategy of co-registration of both images allowed precise targeting of the substrate. In this case, the second treatment volume overlapped by 60% with the first one. The second reason for the re-do of SBRT was an unusual character of the substrate-large cardiac fibroma associated with different morphologies of VT from two locations around the tumor. The planned treatment volumes did not overlap. The third reason for repeated SBRT was the large intramural substrate in the setting of advanced heart failure. The first treatment volume targeted arrhythmias originating in the basal inferoseptal region, while the second SBRT was focused on adjacent basal septum without significant overlapping. Our observations suggested that SBRT for VT could be safely repeated in case of later arrhythmia recurrences (i.e., after at least 6 weeks). No acute toxicity was observed and in two cases, no side effects were observed during 32 and 22 months, respectively. To avoid re-do SBRT due to inaccurate targeting, the precise and reproducible strategy of substrate identification and co-registration with CT image should be used.
655    _2
$a kazuistiky $7 D002363
700    1_
$a Peichl, Petr $u Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia
700    1_
$a Šramko, Marek $u Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia
700    1_
$a Cvek, Jakub $u Department of Oncology, University Hospital Ostrava, Ostrava, Czechia $u Department of Oncology, Ostrava University Medical School, Ostrava, Czechia
700    1_
$a Knybel, Lukáš $u Department of Oncology, University Hospital Ostrava, Ostrava, Czechia
700    1_
$a Jiravský, Otakar $u Department of Cardiology, Podlesí Hospital Trinec, Trinec, Czechia
700    1_
$a Neuwirth, Radek $u Department of Cardiology, Podlesí Hospital Trinec, Trinec, Czechia $u Department of Cardiology, Masaryk University Medical School, Brno, Czechia
700    1_
$a Kautzner, Josef $u Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia
773    0_
$w MED00198704 $t Frontiers in cardiovascular medicine $x 2297-055X $g Roč. 9, č. - (2022), s. 845382
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35425817 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220718 $b ABA008
991    __
$a 20220720100241 $b ABA008
999    __
$a ind $b bmc $g 1816622 $s 1168754
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 9 $c - $d 845382 $e 20220328 $i 2297-055X $m Frontiers in cardiovascular medicine $n Front Cardiovasc Med $x MED00198704
LZP    __
$a Pubmed-20220718

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace